On-Q-ity Adds $5M to Series A Financing Round | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics startup On-Q-ity said yesterday that it has received a $5 million investment from Atlas Ventures, bringing its total Series A financing funding to $26 million.

In November, On-Q-ity closed the first $21 million Series A financing round, which was led by MDV-Mohr Davidow Ventures. Bessemer Venture Partners, Physic Ventures, and Northgate Capital also participated in the financing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.